Ok Biotech Co Ltd Asset Resilience Ratio
Ok Biotech Co Ltd asset resilience ratio. Ok Biotech Co Ltd (4155) has an Asset Resilience Ratio of 0.32% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 4155 defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Ok Biotech Co Ltd (2021–2025)
Asset resilience ratio of Ok Biotech Co Ltd from 2021 to 2025. This chart shows how Ok Biotech Co Ltd's Asset Resilience Ratio has changed over time. Read total liabilities of Ok Biotech Co Ltd for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Ok Biotech Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see 4155 total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 0% |
| Short-term Investments | NT$12.74 Million | 0.32% |
| Total Liquid Assets | NT$12.74 Million | 0.32% |
Asset Resilience Insights
- Limited Liquidity: Ok Biotech Co Ltd maintains only 0.32% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Ok Biotech Co Ltd Industry Peers by Asset Resilience Ratio
Compare Ok Biotech Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Ok Biotech Co Ltd Asset Resilience Ratio by Year (2021–2025)
Ok Biotech Co Ltd asset resilience ratio by year from 2021 to 2025. The table below shows the annual Asset Resilience Ratio data for Ok Biotech Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.33% | NT$12.59 Million ≈ $396.53K |
NT$3.85 Billion ≈ $121.28 Million |
-0.03pp |
| 2024-12-31 | 0.35% | NT$13.04 Million ≈ $410.89K |
NT$3.70 Billion ≈ $116.42 Million |
-1.03pp |
| 2023-12-31 | 1.38% | NT$42.31 Million ≈ $1.33 Million |
NT$3.07 Billion ≈ $96.64 Million |
+0.07pp |
| 2022-12-31 | 1.31% | NT$40.23 Million ≈ $1.27 Million |
NT$3.06 Billion ≈ $96.44 Million |
-0.28pp |
| 2021-12-31 | 1.59% | NT$44.78 Million ≈ $1.41 Million |
NT$2.81 Billion ≈ $88.62 Million |
-- |
About Ok Biotech Co Ltd
OK Biotech Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of blood glucose monitoring systems and homecare healthcare devices in Taiwan, the rest of Asia, America, Africa, and Europe. The company offers nebulizers, blood glucose meters, glucometers, blood sugar meters, and blood glucose test strips. It also provides OTC hearing aids, multi-f… Read more